Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-24

Clinical Trial Update: Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating low-dose total-body irradiation and fludarabine phosphate followed by donor peripheral blood stem cell transplant for stage IV ren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donor peripheral blood stem cell transplant
  • Fludarabine phosphate (Fludarabine phosphate)
  • Total Body Irradiation

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer | Phase 1, Phase 2 | Status: COMPLETED